SEP 11, 2026 · PHASE 1/2 TRIAL
First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671
ClinicalTrials.gov
This is a first-in-human Phase 1/2 trial registration with no results posted; it describes planned safety, tolerability, and pharmacokinetic endpoints in an ongoing recruitment study.
Reported
Planned enrollment164
Study phasePhase 1/2
Primary outcome measure (safety)Number of participants with one or more adv…